340195 <common-name>(5z)-3-(3-methoxypropyl)-5-[[9-methyl-2-(3-morpholin-4-ylpropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5z)-3-(3-methoxypropyl)-5-[[9-methyl-2-(3-morpholin-4-ylpropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C24H31N5O4S2. With an average molecular weight of 517.70 g/mol, (5z)-3-(3-methoxypropyl)-5-[[9-methyl-2-(3-morpholin-4-ylpropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>477735-20-9</cas> <pubchem-id>5876901</pubchem-id> <chemical-formula>C24H31N5O4S2</chemical-formula> <weight>517.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T23:42:05Z</created-at> <updated-at type="dateTime">2026-08-30T23:42:05Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=CN2C1=NC(=C(C2=O)C=C3C(=O)N(C(=S)S3)CCCOC)NCCCN4CCOCC4</moldb-smiles> <moldb-formula>C24H31N5O4S2</moldb-formula> <moldb-inchi>InChI=1S/C24H31N5O4S2/c1-17-6-3-9-28-21(17)26-20(25-7-4-8-27-11-14-33-15-12-27)18(22(28)30)16-19-23(31)29(24(34)35-19)10-5-13-32-2/h3,6,9,16,25H,4-5,7-8,10-15H2,1-2H3/b19-16-</moldb-inchi> <moldb-inchikey>PDPXDKOZRHDRQH-MNDPQUGUSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">517.1817468</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM336088</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-3-(3-methoxypropyl)-5-[[9-methyl-2-(3-morpholin-4-ylpropylamino)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Pyridopyrimidines</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0290611</sync-id> <structure-inchikey>PDPXDKOZRHDRQH-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000000000000100080814000000000000000000000000000010000000000000040400000002000000002000000200000080000000000000000000200008000100000000000001008008000000000002480101000030008000000000000000000000000000000004000010001000000000002010012000000000000040000000000004000000080040000000000408000000000000000000000000000000000000000000000000000000208010004008100016000000200a000010000000000000000000000000000000000000000000000008000842000000200000000019000000000000041200040000000810000000000000058000001000000000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQdAKAAAAAMDBkAoAAAAAwQH QCgAAAADAwZAKAAAAAMEBkAoAAAAAwQGQCgAAAADBAgAKAAAAAMCBgBoAAAA AwMBBgAoAAAAAwQGACgAAAADBAgAKAAAAAMCBwAoAAAAAwMGACgAAAADBBAA KAAAAAMCEAAgAAAAAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAggAIAAAAAIG AGAAAAABAwcAaAAAAAMCAQYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgcAIAAA AAMGAGAAAAACAgYAYAAAAAICCAAgAAAAAgYAYAAAAAICBgBgAAAAAgILAAEA AQJoDAIDaAwDBGgMBAVoDAUGaAwGB2gMBwhoDAgJaAwJCmgMCgsoAgkMIAwN KAINDiAODygCDhAgEBEgERIoAhETABAUABQVABUWABYXABcYAAgZIBkaABob ABscABwdAB0eAB4fAB8gACAhACEiAAYBaAwKBWgMEw0AIh0AQgQAAAAGAQYF BAMCBgcICQoFBgUODRMREAYeHyAhIh0XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:40:31Z</structure-indexed-at> </compound>